Thematische Bibliographien / Porphobilinogène / Zeitschriftenartikel
Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Porphobilinogène.

Zeitschriftenartikel zum Thema „Porphobilinogène“

Autor: Grafiati
Veröffentlicht am 29. März 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Porphobilinogène" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Deybach, J. C., und H. Puy. „Porphobilinogène (PBG) : précurseur de la biosynthèse de l'hème“. EMC - Biologie médicale 5, Nr. 3 (Januar 2010): 1–4. http://dx.doi.org/10.1016/s2211-9698(10)71427-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Deybach, J. C., und H. Puy. „Porphobilinogène (PBG) : précurseur de la biosynthèse de l'hème“. EMC - Biologie Médicale 5, Nr. 3 (2010): 1–4. https://doi.org/10.1016/s0000-0000(10)51137-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Schmitt, C., A. Poli, H. Manceau, H. Puy, L. Gouya und T. Lefebvre. „Acide delta-aminolévulinique et porphobilinogène : précurseurs de la biosynthèse de l’hème“. EMC - Biologie Médicale 18, Nr. 1 (Januar 2023): 1–7. https://doi.org/10.1016/s2211-9698(22)43395-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Mami, I., A. Karras, H. Puy, P. Beaune, É. Thervet und N. Pallet. „Caractérisation des modifications phénotypiques épithéliales rénales induites par l’acide delta aminolévulinique et le porphobilinogène“. Néphrologie & Thérapeutique 9, Nr. 5 (September 2013): 380–81. http://dx.doi.org/10.1016/j.nephro.2013.07.356.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Leeper, Finian J., und Martin Rock. „Interaction of analogues of porphobilinogen with porphobilinogen deaminase“. Journal of the Chemical Society, Perkin Transactions 1, Nr. 21 (1996): 2643. http://dx.doi.org/10.1039/p19960002643.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

SHOOLINGIN-JORDAN, Peter M., Martin J. WARREN und Sarah J. AWAN. „Discovery that the assembly of the dipyrromethane cofactor of porphobilinogen deaminase holoenzyme proceeds initially by the reaction of preuroporphyrinogen with the apoenzyme“. Biochemical Journal 316, Nr. 2 (01.06.1996): 373–76. http://dx.doi.org/10.1042/bj3160373.

Der volle Inhalt der Quelle
Annotation:
The assembly process of the dipyrromethane cofactor of Escherichia coli porphobilinogen deaminase holoenzyme is initiated by the reaction of the porphobilinogen deaminase apoenzyme with preuroporphyrinogen. The resulting enzyme-bound tetrapyrrole (bilane) is equivalent to the holoenzyme intermediate complex ES2 and yields the dipyrromethane cofactor by reactions of the normal catalytic cycle. These observations indicate that preuroporphyrinogen, rather than porphobilinogen, is the preferred precursor for the dipyrromethane cofactor and explain the existence of the D84A and D84N deaminase mutants as catalytically inactive ES2 complexes.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Jordan, P. M., und P. N. Gibbs. „Mechanism of action of 5-aminolaevulinate dehydratase from human erythrocytes“. Biochemical Journal 227, Nr. 3 (01.05.1985): 1015–20. http://dx.doi.org/10.1042/bj2271015.

Der volle Inhalt der Quelle
Annotation:
Purified 5-aminolaevulinate dehydratase (porphobilinogen synthase, EC 4.2.1.24) from human erythrocytes was incubated initially with limiting amounts of 5-amino [5-14C]laevulinate in a rapid-mixing apparatus. The single-turnover reaction with respect to the bound labelled 5-aminolaevulinate was completed by the addition of unlabelled 5-aminolaevulinate and the resulting radioactive porphobilinogen was isolated and degraded. The 14C label was found to be located predominantly at C-2 of the product, demonstrating that, of the two substrate molecules participating in the reaction, the 5-aminolaevulinate molecule initially bound to the enzyme provides the propionic acid ‘side’ of the porphobilinogen. The same enzyme-[14C]substrate species that yields regiospecific porphobilinogen may be trapped by reaction with NaBH4, showing that the substrate molecule initially bound to the enzyme does so in the form of a Schiff base. A conventional incubation with 5-amino[5-14C]laevulinate yielded porphobilinogen with an equal distribution of the label between C-2 and C-11. The reaction mechanism of the human erythrocyte 5-aminolaevulinate dehydratase thus follows the same course as that of other dehydratases studied in our laboratory by using single-turnover techniques.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Hsiao, Kwang-Jen, Fa-Yauh Lee, Shew-Jen Wu und Wei-Jan Chang. „Determination of erythrocyte porphobilinogen deaminase activity using porphobilinogen as substrate“. Clinica Chimica Acta 168, Nr. 2 (September 1987): 257–58. http://dx.doi.org/10.1016/0009-8981(87)90296-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Hart, G. J., C. Abell und A. R. Battersby. „Purification, N-terminal amino acid sequence and properties of hydroxymethylbilane synthase (porphobilinogen deaminase) from Escherichia coli“. Biochemical Journal 240, Nr. 1 (15.11.1986): 273–76. http://dx.doi.org/10.1042/bj2400273.

Der volle Inhalt der Quelle
Annotation:
Hydroxymethylbilane synthase (porphobilinogen deaminase) was purified to apparent homogeneity from Escherichia coli. The enzyme is a monomer of Mr approx. 40,000. The Km for porphobilinogen and relative Vmax. values have been obtained at various pH values over the range 6.2-8.8, enabling pK values for ionizable groups important for activity to be determined. The N-terminal amino acid sequence is presented.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Heinemann, Ilka U., Claudia Schulz, Wolf-Dieter Schubert, Dirk W. Heinz, Yang-G. Wang, Yuichi Kobayashi, Yuuki Awa, Masaaki Wachi, Dieter Jahn und Martina Jahn. „Structure of the Heme Biosynthetic Pseudomonas aeruginosa Porphobilinogen Synthase in Complex with the Antibiotic Alaremycin“. Antimicrobial Agents and Chemotherapy 54, Nr. 1 (12.10.2009): 267–72. http://dx.doi.org/10.1128/aac.00553-09.

Der volle Inhalt der Quelle
Annotation:
ABSTRACT The recently discovered antibacterial compound alaremycin, produced by Streptomyces sp. A012304, structurally closely resembles 5-aminolevulinic acid, the substrate of porphobilinogen synthase. During the initial steps of heme biosynthesis, two molecules of 5-aminolevulinic acid are asymmetrically condensed to porphobilinogen. Alaremycin was found to efficiently inhibit the growth of both Gram-negative and Gram-positive bacteria. Using the newly created heme-permeable strain Escherichia coli CSA1, we are able to uncouple heme biosynthesis from bacterial growth and demonstrate that alaremycin targets the heme biosynthetic pathway. Further studies focused on the activity of alaremycin against the opportunistic pathogenic bacterium Pseudomonas aeruginosa. The MIC of alaremycin was determined to be 12 mM. Alaremycin was identified as a direct inhibitor of recombinant purified P. aeruginosa porphobilinogen synthase and had a Ki of 1.33 mM. To understand the molecular basis of alaremycin's antibiotic activity at the atomic level, the P. aeruginosa porphobilinogen synthase was cocrystallized with the alaremycin. At 1.75-Å resolution, the crystal structure reveals that the antibiotic efficiently blocks the active site of porphobilinogen synthase. The antibiotic binds as a reduced derivative of 5-acetamido-4-oxo-5-hexenoic acid. The corresponding methyl group is, however, not coordinated by any amino acid residues of the active site, excluding its functional relevance for alaremycin inhibition. Alaremycin is covalently bound by the catalytically important active-site lysine residue 260 and is tightly coordinated by several active-site amino acids. Our data provide a solid structural basis to further improve the activity of alaremycin for rational drug design. Potential approaches are discussed.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
11

Fontanellas, A., J. A. Herrero, F. Coronel, J. L. Santos, M. J. Morán, A. Barrientos und R. Enríquez de Salamanca. „Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis.“ Journal of the American Society of Nephrology 7, Nr. 5 (Mai 1996): 774–79. http://dx.doi.org/10.1681/asn.v75774.

Der volle Inhalt der Quelle
Annotation:
Recombinant human erythropoietin (r-HuEPO) is being successfully used for the treatment of uremic anemia. Several abnormalities of heme biosynthetic pathway have been described in patients with end-stage renal failure. In this condition, the activity of erythrocyte porphobilinogen deaminase has been found to be slightly increased. If this enzyme were to be the key enzyme in erythroid heme regulation, its activity would be increased to an even greater degree during the correction of uremic anemia. To assess this hypothesis, this study followed the variations of this and other parameters of porphyrin metabolism over 12 months of erythropoietin therapy in eight patients with nephrogenic anemia who underwent hemodialysis. By the first month of therapy, an increase of the previously depressed erythrocyte activity of aminolevulinate dehydratase was already evident, in coincidence with a nonsignificant increase of the reticulocyte count. The activity of this enzyme reached its maximal level by Month 3, and did not change up to Month 10. The porphobilinogen deaminase hyperactivity normalized at Month 4. By Month 12, in coincidence with the reduction of erythropoietin doses, the maximal levels of erythrocyte protoporphyrin, and the decrease in aminolevulinate dehydratase activity, the porphobilinogen deaminase values started to increase once again. In conclusion, the administration of r-HuEPO to hemodialyzed patients induced transient normalization of the previously observed porphyrin metabolism abnormalities. However, erythrocyte porphobilinogen deaminase activity did not rise concomitantly with the increase in hematocrit or hemoglobin values, but it did diminish during treatment. Therefore, porphobilinogen deaminase did not behave as a controlling enzyme in heme synthesis during the r-HuEPO-induced correction of uremic anemia.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
12

Rossetti, M. V., A. A. Juknat und A. M. del C. Batlle. „Soluble and Particulate Porphobilinogen-Deaminase from Dark-Grown Euglena gracilis“. Zeitschrift für Naturforschung C 44, Nr. 7-8 (01.08.1989): 578–80. http://dx.doi.org/10.1515/znc-1989-7-807.

Der volle Inhalt der Quelle
Annotation:
A highly efficient method employing NaSCN as a chaotropic agent was used to dissociate the membrane-bound porphobilinogen-deaminase. The same sequence of steps was applied for purifying both soluble and membrane dissociated porphobilinogen-deam inase. The chromatographic behaviour of both proteins was quite similar. Euglena gracilis deam inase appears to exist in an equilibrium mixture of two active species of relative molecular masses of 40000 and 20000.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
13

Biel, Alan J., Keith Canada, David Huang, Karl Indest und Karen Sullivan. „Oxygen-Mediated Regulation of Porphobilinogen Formation in Rhodobacter capsulatus“. Journal of Bacteriology 184, Nr. 6 (15.03.2002): 1685–92. http://dx.doi.org/10.1128/jb.184.6.1685-1692.2002.

Der volle Inhalt der Quelle
Annotation:
ABSTRACT A Rhodobacter capsulatus hemC mutant has been isolated and used to show that oxygen regulates the intracellular levels of porphobilinogen. Experiments using a hemB-cat gene fusion demonstrated that oxygen does not transcriptionally regulate hemB transcription. Porphobilinogen synthase activity is not regulated by oxygen nor is the enzyme feedback inhibited by hemin or protoporphyrin IX. It was demonstrated that less than 20% of [14C]aminolevulinate was incorporated into bacteriochlorophyll, suggesting that the majority of the aminolevulinate is diverted from the common tetrapyrrole pathway. Porphobilinogen oxygenase activity was not observed in this organism; however, an NADPH-linked aminolevulinate dehydrogenase activity was demonstrated. The specific activity of this enzyme increased with increasing oxygen tension. The results presented here suggest that carbon flow over the common tetrapyrrole pathway is regulated by a combination of feedback inhibition of aminolevulinate synthase and diversion of aminolevulinate from the pathway by aminolevulinate dehydrogenase.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
14

Shimoni-Livny, L., H. L. Carrell, T. Wagner, A. Kaufman Katz, C. Afshar, L. W. Mitchell, M. Volin, E. K. Jaffe und J. P. Glusker. „Crystallization and preliminary X-ray diffraction studies of E. coli porphobilinogen synthase and its heavy-atom derivatives“. Acta Crystallographica Section D Biological Crystallography 54, Nr. 3 (01.05.1998): 438–40. http://dx.doi.org/10.1107/s0907444997010925.

Der volle Inhalt der Quelle
Annotation:
Porphobilinogen synthase (PBGS) catalyzes the condensation of two identical substrate molecules, 5-aminolevulinic acid (ALA), in an asymmetric manner to form porphobilinogen. E. coli PBGS is an homooctameric enzyme. The number of active sites is not clear, but each subunit binds one ZnII ion and one MgII ion. Diffraction-quality crystals of native E. coli PBGS have been obtained, and unit-cell dimensions (a = 130.8, c = 144.0 Å) are reported. These crystals diffract to about 3.0 Å resolution.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
15

Cheung, Kwai-Ming, und Peter M. Shoolingin-Jordan. „Facile Chemical Syntheses of Porphobilinogen Analogues: A Four-Step Synthesis of iso-Porphobilinogen“. Synthesis 2001, Nr. 11 (2001): 1627–30. http://dx.doi.org/10.1055/s-2001-16752.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
16

García, Susana Raquel Correa, Maria Victoria Rossetti und Alcira María del Carmen Batlle. „Studies on Porphobilinogen-Deaminase from Saccharomyces cerevisiae“. Zeitschrift für Naturforschung C 46, Nr. 11-12 (01.12.1991): 1017–23. http://dx.doi.org/10.1515/znc-1991-11-1215.

Der volle Inhalt der Quelle
Annotation:
Abstract Porphobilinogen-deaminase from Saccharomyces cerevisiae has been isolated and partially purified 80-and 230-fold in the absence or presence of phenylmethylsulphonyl fluoride, respectively.Some properties of the isolated enzyme were studied. Porphyrin formation was linear with time and protein concentration. Optimum pH was about 7.5-7.8. Molecular mass of the protein was 30,000 ± 3000 Dalton when the enzyme was purified in the presence of phenylmethyl­ sulphonyl fluoride. A less active and unstable 20,000 Da molecular mass species was obtained when purification was performed in the absence of the protease inhibitor.Porphobilinogen-deaminase exhibited classical Michaelis-Menten kinetics. The apparent Km for uroporphyrinogen formation was 19 μм; Vmax was 3.6 nmol uroporphyrin/h and the Hill coefficient was n = 1.Also the action of several reagents on the activity was studied. Protective thiol agents had no effect. Heavy metals inhibited both porphyrin formation and porphobilinogen consumption, but known sulphydryl inactivating chemicals inhibit the former without modifying the latter. Ammonium ions had no effect on the activity while hydroxylamine completely inhibited both porphyrin formation and porphobilinogen consumption.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
17

Woolf, Jacqueline, Joanne T. Marsden, Timothy Degg, Sharon Whatley, Paul Reed, Nadia Brazil, M. Felicity Stewart und Michael Badminton. „Best practice guidelines on first-line laboratory testing for porphyria“. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 54, Nr. 2 (19.01.2017): 188–98. http://dx.doi.org/10.1177/0004563216667965.

Der volle Inhalt der Quelle
Annotation:
The porphyrias are disorders of haem biosynthesis which present with acute neurovisceral attacks or disorders of sun-exposed skin. Acute attacks occur mainly in adults and comprise severe abdominal pain, nausea, vomiting, autonomic disturbance, central nervous system involvement and peripheral motor neuropathy. Cutaneous porphyrias can be acute or chronic presenting at various ages. Timely diagnosis depends on clinical suspicion leading to referral of appropriate samples for screening by reliable biochemical methods. All samples should be protected from light. Investigation for an acute attack: • Porphobilinogen (PBG) quantitation in a random urine sample collected during symptoms. Urine concentration must be assessed by measuring creatinine, and a repeat requested if urine creatinine <2 mmol/L. • Urgent porphobilinogen testing should be available within 24 h of sample receipt at the local laboratory. Urine porphyrin excretion (TUP) should subsequently be measured on this urine. • Urine porphobilinogen should be measured using a validated quantitative ion-exchange resin-based method or LC-MS. • Increased urine porphobilinogen excretion requires confirmatory testing and clinical advice from the National Acute Porphyria Service. • Identification of individual acute porphyrias requires analysis of urine, plasma and faecal porphyrins. Investigation for cutaneous porphyria: • An EDTA blood sample for plasma porphyrin fluorescence emission spectroscopy and random urine sample for TUP. • Whole blood for porphyrin analysis is essential to identify protoporphyria. • Faeces need only be collected, if first-line tests are positive or if clinical symptoms persist. Investigation for latent porphyria or family history: • Contact a specialist porphyria laboratory for advice. Clinical, family details are usually required.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
18

Leeper, Finian J., Martin Rock und Diana Appleton. „Synthesis of analogues of porphobilinogen“. Journal of the Chemical Society, Perkin Transactions 1, Nr. 21 (1996): 2633. http://dx.doi.org/10.1039/p19960002633.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
19

Gorchein, Abel. „Testing for Porphobilinogen in Urine“. Clinical Chemistry 48, Nr. 3 (01.03.2002): 564–66. http://dx.doi.org/10.1093/clinchem/48.3.564.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
20

Beaumont, C., C. Porcher, C. Picat, Y. Nordmann und B. Grandchamp. „The Mouse Porphobilinogen Deaminase Gene“. Journal of Biological Chemistry 264, Nr. 25 (September 1989): 14829–34. http://dx.doi.org/10.1016/s0021-9258(18)63775-5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
21

Noriega, Guillermo, Guillermo Mattei, Alcira Batlle und Adela Ana Juknat. „Rat kidney porphobilinogen deaminase kinetics“. International Journal of Biochemistry & Cell Biology 34, Nr. 10 (Oktober 2002): 1230–40. http://dx.doi.org/10.1016/s1357-2725(02)00051-1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
22

Umanoff, H., C. S. Russell und S. D. Cosloy. „Availability of porphobilinogen controls appearance of porphobilinogen deaminase activity in Escherichia coli K-12.“ Journal of Bacteriology 170, Nr. 10 (1988): 4969–71. http://dx.doi.org/10.1128/jb.170.10.4969-4971.1988.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
23

Leeper, Finian J., und Martin Rock. „Modified substrates for tetrapyrrole biosynthesis: analogues of porphobilinogen showing unusual inhibition of porphobilinogen deaminase“. Journal of the Chemical Society, Chemical Communications, Nr. 3 (1992): 242. http://dx.doi.org/10.1039/c39920000242.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
24

Kondo, M., und G. Urata. „Radiochemical microassay of delta-aminolevulinic acid dehydratase activity in whole blood and bone marrow.“ Clinical Chemistry 31, Nr. 3 (01.03.1985): 427–29. http://dx.doi.org/10.1093/clinchem/31.3.427.

Der volle Inhalt der Quelle
Annotation:
Abstract We describe an assay for delta-aminolevulinic acid dehydratase (EC 4.2.1.24) activity. Radioactive [14C]porphobilinogen, formed by action of this enzyme on [14C]delta-aminolevulinic acid, is purified by passage through an ion-exchange chromatographic column before measurement with a liquid scintillation counter. The radioactive substance in the final solution was identified as solely [14C]porphobilinogen by paper-chromatographic analysis. The present assay procedure requires only a 0.1-microL sample of blood and is about 100-fold more sensitive than the conventional colorimetric methods involving Ehrlich's reagent. Using this method, we found that activity of this enzyme in the bone marrow of rats decreases abruptly and sharply two weeks after birth.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
25

Jordan, P. M., S. D. Thomas und M. J. Warren. „Purification, crystallization and properties of porphobilinogen deaminase from a recombinant strain of Escherichia coli K12“. Biochemical Journal 254, Nr. 2 (01.09.1988): 427–35. http://dx.doi.org/10.1042/bj2540427.

Der volle Inhalt der Quelle
Annotation:
Porphobilinogen deaminase has been purified and crystallized from an overproducing recombinant strain of Escherichia coli harbouring a hemC-containing plasmid which has permitted the purification of milligram quantities of the enzyme. Determination of the Mr of the enzyme by SDS/polyacrylamide-gel electrophoresis (35,000) and gel filtration (32,000) agrees with the gene-derived Mr of 33,857. The enzyme has a Km of 19 +/- 7 microM, an isoelectric point of 4.5 and an N-terminal sequence NH2-MLDNVLRIAT. The substrate, porphobilinogen, binds to the active-site dipyrromethane cofactor to form three intermediate complexes: ES, ES2 and ES3. The gene-derived primary structure of the E. coli deaminase is compared with that derived from the cDNA of the human enzyme.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
26

Kotler, ML, AA Juknat, SA Fumagalli und AM Batlle. „Involvement of free and enzyme‐bound intermediates in the reaction mechanism catalyzed by the bovine liver immobilized porphobilinogen deaminase. Proof that they are substrates for cosynthetase in uroporphyrinogen III biosynthesis“. Biotechnology and Applied Biochemistry 13, Nr. 2 (April 1991): 173–80. http://dx.doi.org/10.1111/j.1470-8744.1991.tb00150.x.

Der volle Inhalt der Quelle
Annotation:
The detection and accumulation of tetrapyrrole intermediates synthesized by the action of bovine liver porphobilinogen deaminase immobilized to Sepharose 4B is reported. Employing Sepharose‐deaminase preparations, two phases in uroporphyrinogen I synthesis as a function of time were observed, suggesting the accumulation of free and enzyme‐bound intermediates, the concentration and distribution of which were time dependent. The deaminase‐bound intermediate behaves as a substrate in uroporphyrinogen I synthesis whereas the free intermediates produce enzyme inhibition. The tetrapyrrole intermediate bound to the Sepharose‐enzyme is removed from the protein by the binding of porphobilinogen. Free as well as enzyme‐bound intermediates are shown to be substrates for cosynthetase with formation of 80% uroporphyrinogen III.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
27

Pichon, Clotilde, Karen R. Clemens, Alan R. Jacobson und A. Ian Scott. „On the mechanism of porphobilinogen deaminase. Design, synthesis, and enzymatic reactions of novel porphobilinogen analogs.“ Tetrahedron 48, Nr. 23 (Juni 1992): 4687–712. http://dx.doi.org/10.1016/s0040-4020(01)81567-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
28

Cheung, Kwai-Ming, und Peter M. Shoolingin-Jordan. „ChemInform Abstract: Facile Chemical Syntheses of Porphobilinogen Analogues: A Four-Step Synthesis to iso-Porphobilinogen.“ ChemInform 32, Nr. 51 (23.05.2010): no. http://dx.doi.org/10.1002/chin.200151130.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
29

Lawrence, Sarah H., Ursula D. Ramirez, Trevor Selwood, Linda Stith und Eileen K. Jaffe. „Allosteric Inhibition of Human Porphobilinogen Synthase“. Journal of Biological Chemistry 284, Nr. 51 (07.10.2009): 35807–17. http://dx.doi.org/10.1074/jbc.m109.026294.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
30

Jamani, A., M. Pudek und W. E. Schreiber. „Liquid-chromatographic assay of urinary porphobilinogen.“ Clinical Chemistry 35, Nr. 3 (01.03.1989): 471–75. http://dx.doi.org/10.1093/clinchem/35.3.471.

Der volle Inhalt der Quelle
Annotation:
Abstract This is a rapid (10 min per sample), highly sensitive procedure for quantifying urinary porphobilinogen (PBG). Interfering substances are removed by selectively adsorbing PBG onto an ion-exchange resin. After PBG is eluted with 0.5 mol/L formic acid, Ehrlich's reagent is added to produce the chromophore, which is then injected into a liquid chromatograph equipped with a diode-array detector. PBG is separated by a linear gradient (10% to 100%) of methanol in 10 mmol/L phosphate buffer, pH 3.0. Absorbance is monitored at 555 nm. Assay response varies linearly with PBG concentration over the range 0-110 mumol/L (0-25 mg/L). As little as 1.5 mumol/L (0.3 mg/L) can be detected. In prepared urine samples with known PBG concentrations, the within-run coefficient of variation (CV) ranged from 1.7% to 3.2%, the day-to-day CV from 3.5% to 6.1%. PBG concentrations in 24-h urine collected from 25 healthy subjects were all below the detection limit of the assay (less than 1.5 mumol/L). We used the new assay to measure PBG concentrations in the urine of two patients with latent porphyria. This method is more sensitive than spectrophotometric techniques currently used for measuring urinary PBG.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
31

Rietschel, M., M. Nöthen, J. Körner, M. Lanczik, J. Erdmann, S. Cichon, H. J. Möller und P. Propping. „PORPHOBILINOGEN DEAMINASE GENE ALLELES IN SCHIZOPHRENIA“. Clinical Neuropharmacology 15 (1992): 301B. http://dx.doi.org/10.1097/00002826-199202001-00582.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
32

McNeill, Luke A., und Peter M. Shoolingin-Jordan. „Dipyrromethane cofactor assembly in porphobilinogen deaminase“. Biochemical Society Transactions 26, Nr. 3 (01.08.1998): S286. http://dx.doi.org/10.1042/bst026s286.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
33

Jaffe, Eileen K. „The porphobilinogen synthase family of metalloenzymes“. Acta Crystallographica Section D Biological Crystallography 56, Nr. 2 (01.02.2000): 115–28. http://dx.doi.org/10.1107/s0907444999014894.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
34

Jaffe, Eileen K. „The Remarkable Character of Porphobilinogen Synthase“. Accounts of Chemical Research 49, Nr. 11 (26.10.2016): 2509–17. http://dx.doi.org/10.1021/acs.accounts.6b00414.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
35

Clemens, Karen R., Clotilde Pichon, Alan R. Jacobson, Paul Yon-Hin, Mario D. Gonzalez und A. Ian Scott. „Systematic specificity studies on porphobilinogen deaminase“. Bioorganic & Medicinal Chemistry Letters 4, Nr. 3 (Februar 1994): 521–24. http://dx.doi.org/10.1016/0960-894x(94)80029-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
36

Jaffe, Eileen K. „The porphobilinogen synthase catalyzed reaction mechanism“. Bioorganic Chemistry 32, Nr. 5 (Oktober 2004): 316–25. http://dx.doi.org/10.1016/j.bioorg.2004.05.010.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
37

Buttery, Joseph E., Anna-Maria Carrera und Peter R. Pannall. „Reliability of the porphobilinogen screening assay“. Pathology 22, Nr. 4 (1990): 197–98. http://dx.doi.org/10.3109/00313029009086660.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
38

Shanmugam, Dhanasekaran, Bo Wu, Ursula Ramirez, Eileen K. Jaffe und David S. Roos. „Plastid-associated Porphobilinogen Synthase fromToxoplasma gondii“. Journal of Biological Chemistry 285, Nr. 29 (04.05.2010): 22122–31. http://dx.doi.org/10.1074/jbc.m110.107243.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
39

Bung, Navneet, Arijit Roy, U. Deva Priyakumar und Gopalakrishnan Bulusu. „Computational modeling of the catalytic mechanism of hydroxymethylbilane synthase“. Physical Chemistry Chemical Physics 21, Nr. 15 (2019): 7932–40. http://dx.doi.org/10.1039/c9cp00196d.

Der volle Inhalt der Quelle
Annotation:
Hydroxymethylbilane synthase (HMBS), the third enzyme in the heme biosynthesis pathway, catalyzes the formation of 1-hydroxymethylbilane (HMB) by a stepwise polymerization of four molecules of porphobilinogen (PBG) using the dipyrromethane (DPM) cofactor.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
40

Kaur, Tanpreet, Preeti Wadhwa und Anuj Sharma. „Arylsulfonylmethyl isocyanides: a novel paradigm in organic synthesis“. RSC Advances 5, Nr. 65 (2015): 52769–87. http://dx.doi.org/10.1039/c5ra07876h.

Der volle Inhalt der Quelle
Annotation:
p-Tosylmethyl isocyanide (TosMIC), an α-acidic isocyanide has emerged as a privileged reagent to access biologically relevant fused heterocycles and some natural products like (−)-ushikulide A, variolin B, porphobilinogen and mansouramycin B.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
41

Helliwell, John R. „The crystal structures of the enzyme hydroxymethylbilane synthase, also known as porphobilinogen deaminase“. Acta Crystallographica Section F Structural Biology Communications 77, Nr. 11 (19.10.2021): 388–98. http://dx.doi.org/10.1107/s2053230x2100964x.

Der volle Inhalt der Quelle
Annotation:
The enzyme hydroxymethylbilane synthase (HMBS; EC 4.3.1.8), also known as porphobilinogen deaminase, catalyses the stepwise addition of four molecules of porphobilinogen to form the linear tetrapyrrole 1-hydroxymethylbilane. Thirty years of crystal structures are surveyed in this topical review. These crystal structures aim at the elucidation of the structural basis of the complex reaction mechanism involving the formation of tetrapyrrole from individual porphobilinogen units. The consistency between the various structures is assessed. This includes an evaluation of the precision of each molecular model and what was not modelled. A survey is also made of the crystallization conditions used in the context of the operational pH of the enzyme. The combination of 3D structural techniques, seeking accuracy, has also been a feature of this research effort. Thus, SAXS, NMR and computational molecular dynamics have also been applied. The general framework is also a considerable chemistry research effort to understand the function of the enzyme and its medical pathologies in acute intermittent porphyria (AIP). Mutational studies and their impact on the catalytic reaction provide insight into the basis of AIP and are also invaluable for guiding the understanding of the crystal structure results. Future directions for research on HMBS are described, including the need to determine the protonation states of key amino-acid residues identified as being catalytically important. The question remains – what is the molecular engine for this complex reaction? Thermal fluctuations are the only suggestion thus far.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
42

Wei, Ho-Chun, Huidy Shu und James V. Price. „Functional genomic analysis of the 61D-61F region of the third chromosome of Drosophila melanogaster“. Genome 46, Nr. 6 (01.12.2003): 1049–58. http://dx.doi.org/10.1139/g03-081.

Der volle Inhalt der Quelle
Annotation:
Assigning functional significance to completed genome sequences is one of the next challenges in biological science. Conventional genetic tools such as deficiency chromosomes help assign essential complementation groups to their corresponding genes. We describe an F2 genetic screen to identify lethal mutations within cytogenetic region 61D-61F of the third chromosome of Drosophila melanogaster. One hundred sixteen mutations were identified by their failure to complement both Df(3L)bab-PG and Df(3L)3C7. These alleles were assigned to 14 complementation groups and 9 deficiency intervals. Complementation groups were ordered using existing deficiencies, as well as new deficiencies generated in this study. With the aid of the genomic sequence, genetic and physical maps in the region were correlated by use of PCR to localize the breakpoints of deficiencies within a 268-kb genomic contig (GenBank accession No. AC005847). Six essential complementation groups were assigned to specific genes, including genes encoding a porphobilinogen deaminase and a Sac1-like protein.Key words: Drosophila, functional genomics, porphobilinogen deaminase, synaptojanin.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
43

Luo, J., und C. K. Lim. „Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase“. Biochemical Journal 289, Nr. 2 (15.01.1993): 529–32. http://dx.doi.org/10.1042/bj2890529.

Der volle Inhalt der Quelle
Annotation:
The isomeric compositions of the heptacarboxylic, hexacarboxylic and pentacarboxylic porphyrinogens formed by incubation of porphobilinogen with human red-cell haemolysates have been analysed and compared with those derived from incubation with chemically prepared uroporphyrinogen III as substrate. The results indicated that when supplied with an excess (3.7 microM) of exogenous uroporphyrinogen III, uroporphyrinogen decarboxylase utilized the substrate at random and a mixture of isomers was produced; whereas with uroporphyrinogen III generated enzymically from porphobilinogen as substrate a clockwise decarboxylation sequence was observed, resulting in the formation of intermediates mainly with the ring-D, rings-AD and rings-ABD acetate groups decarboxylated. Using [14C]uroporphyrinogen III as substrate at low concentrations (0.01-0.5 microM) also led to preferential decarboxylation of the ring-D acetate group. It was concluded that the order of uroporphyrinogen III decarboxylation is substrate-concentration-dependent, and under normal physiological conditions enzymic decarboxylation is most probably orderly and clockwise, starting at the ring-D acetate group.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
44

Scott, A. I., N. J. Stolowich, H. J. Williams, M. D. Gonzalez, C. A. Roessner, S. K. Grant und C. Pichon. „Concerning the catalytic site of porphobilinogen deaminase“. Journal of the American Chemical Society 110, Nr. 17 (August 1988): 5898–900. http://dx.doi.org/10.1021/ja00225a051.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
45

Deybach, Jean Charles, und Hervé Puy. „Porphobilinogen deaminase gene structure and molecular defects“. Journal of Bioenergetics and Biomembranes 27, Nr. 2 (April 1995): 197–205. http://dx.doi.org/10.1007/bf02110034.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
46

Mazzetti, Marta B., und J. Maria Tomio. „Characterization of porphobilinogen deaminase from rat liver“. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 957, Nr. 1 (November 1988): 97–104. http://dx.doi.org/10.1016/0167-4838(88)90161-6.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
47

Ostrowski, Jerzy. „Erythrocyte Porphobilinogen Deaminase Activity in Lives Disease“. Gastroenterology 92, Nr. 4 (April 1987): 845–51. http://dx.doi.org/10.1016/0016-5085(87)90956-5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
48

LEEPER, F. J., M. ROCK und D. APPLETON. „ChemInform Abstract: Synthesis of Analogues of Porphobilinogen.“ ChemInform 28, Nr. 34 (03.08.2010): no. http://dx.doi.org/10.1002/chin.199734233.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
49

Evans, J. N. S., P. E. Fagerness, N. E. Mackenzie und A. I. Scott. „1H,3H and13C NMR studies on porphobilinogen“. Magnetic Resonance in Chemistry 23, Nr. 11 (November 1985): 939–44. http://dx.doi.org/10.1002/mrc.1260231112.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
50

Adamczyk, Maciej, und Rajarathnam E. Reddy. „A convenient and versatile synthesis of porphobilinogen“. Tetrahedron Letters 36, Nr. 50 (Dezember 1995): 9121–24. http://dx.doi.org/10.1016/0040-4039(95)01979-r.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Porphobilinogène" für andere Quellenarten können Sie auch interessieren:
Dissertationen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie